• 한국원자력학회:학술대회논문집
• /
• 한국원자력학회 1999년도 춘계학술발표회요약집
• /
• pp.403-403
• /
• 1999

• Nuclear Medicine and Molecular Imaging
• /
• 제43권5호
• /
• pp.505-507
• /
• 2009

A 60-year-old woman, who had non-small-cell lung cancer (NSCLC) in left lower lobe underwent brain F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) for evaluation of cerebral metastasis. On follow-up FDG-PET/CT, only hypometaolic lesion was detected and progressed in right frontal lobe at 6 months and 10 months, later. Hypermetabolic metastasis was not detected even at last scan time of FDG-PET/CT. Brain MRI showed brain metastasis in right frontal lobe. As might be expected, the physician should take cerebral metastasis into consideration even though there is only hypometabolic change on subsequent FDG-PET/CT in patients with NSCLC.

• Nuclear Medicine and Molecular Imaging
• /
• 제42권3호
• /
• pp.246-248
• /
• 2008

A hepatic angiomyolipoma is a rare benign tumor mainly composed of blood vessels, smooth muscle cells and fat cells in varying proportion. Hepatic angiomyolipoma is often misdiagnosed as a hepatocellular carcinoma in preoperative imaging work-up. To date, there has been little published data describing PET findings of hepatic angiomyolipoma. We report one case of hepatic angiomyolipoma that showed a high acetate and relatively low FDG uptake on PET images.

• Nuclear Medicine and Molecular Imaging
• /
• 제43권6호
• /
• pp.588-591
• /
• 2009

A 26-year-old man with renal cell carcinoma underwent $^{99m}Tc$-HDP bone scintigraphy for detecting bony metastasis after left total nephrectomy for renal cell carcinoma. $^{99m}Tc$-HDP bone scintigraphy showed small hot lesion in the first lumbar spine. About 12 months later, he underwent spinal MRI for lower back pain. A large mass was seen around spinous process of the first lumbar spine (L1) on spinal MRI and confirmed as metastatic renal cell carcinoma by bone biopsy. $^{99m}Tc$-HDP bone scintigraphy and $^{18}F$-FDG PET/CT were underwent for further evaluation. $^{99m}Tc$-HDP bone scintigraphy showed cold lesion in the first lumbar spine which was initially hot and newly developed hot lesion in the twelfth thoracic spine, and which were shown as hypermetabolic lesions in $^{18}F$-FDG PET/CT. We report a case of bony metastasis from renal cell carcinoma which is changed from hot lesion to cold lesion in $^{99m}Tc$-HDP bone scintigraphy and compare with $^{18}F$-FDG PET/CT.

• 핵의학기술
• /
• 제13권3호
• /
• pp.43-47
• /
• 2009

$^{18}F$-FDG PET/CT는 암세포에서 당 대사가 항진되는 현상을 이용하여 암환자의 진단에 폭넓게 사용 되고 있으며, 악성 종양에 대부분 섭취 되는 것이 일반적이지만, 정상 조직에도 섭취되는 경우도 있다. 이러한 현상은 보통 소화기계에서 빈번히 일어나며, 월경을 하는 가임기 여성에게서 자궁 주위에서의 섭취가 일어나기도 한다. 특히 가임기 여성은 월경에서 각 주기 동안 난소는 월경기, 증식기, 배란기, 분비기 이렇게 4단계의 주기를 거친다. 이러한 월경 주기에 따른 $^{18}F$-FDG 섭취는 영상에 다양한 영향이 미치기 때문에, 본 연구는 자궁의 $^{18}F$-FDG 섭취와 월경주기와의 관계를 알아보고자 하였다. 2008년 1월부터 2009년 3월까지 부인과 질환이 없고 월경이 규칙적인 $38{\pm}7.93$세 여성 환자 200명을 대상으로 하였다. 검사 전 6~8시간 금식 후 $^{18}F$-FDG 370 MBq를 정맥주사하고, 1시간 동안 충분한 휴식 후 전신 PET/CT 검사를 시행하였다. 영상 분석은 CT 영상으로 난소와 자궁의 위치를 정확히 파악한 후 같은 위상의 영상에서 표준화섭취계수를 측정하여 분석하였다. 월경주기에 따라 SUV의 변화가 크지는 않았지만, 분명 차이가 있었으며, 월경기 $SUV_{max}$는 $3.17{\pm}1.59$, $SUV_{avg}$는 $2.89{\pm}1.04$였고, 증식기 $SUV_{max}$는 $2.98{\pm}1.14$, $SUV_{avg}$는 $2.40{\pm}0.88$였다. 그리고 배란기 $SUV_{max}$는 $3.71{\pm}1.67$, $SUV_{avg}$는 $3.59{\pm}1.76$였고, 분비기 $SUV_{max}$는 $3.1{\pm}1.80$, $SUV_{avg}$는 $2.58{\pm}1.39$였다. 가임기 여성은 월경 주기에 따라 자궁과 난소에서 일정한 주기로 변화가 일어나며, 이에 따라 $^{18}F$-FDG PET/CT에서도 변화가 일어난다. 월경기, 증식기, 배란기, 분비기 이렇게 4단계의 주기를 가지고 영상에서 변화가 일어나므로, 검사 전 가임기 여성의 월경 주기를 파악하여 검사 시에 활용한다면, 자궁주변의 병변의 진단에 큰 도움이 될 것으로 사료된다.

• Nuclear Medicine and Molecular Imaging
• /
• 제43권4호
• /
• pp.352-356
• /
• 2009

Intravascular large B-cell lymphoma (IVLBCL) is a subtype of diffuse large cell lymphoma, characterized by proliferation of lymphoid cells in the intravascular space of various organs without causing a mass effect. Although $^{18}$F-FDG PET is a powerful imaging tool in lymphoma, the usefulness of $^{18}$F-FDG PET in the assessment of IVLBCL is still controversial. $^{99m}$Tc-MIBI, a tumor imaging radiopharmaceutical with a different mechanism from that of $^{18}$F-FDG, has been reported to be also effective in lymphoma. However, there is nearly no report on the efficacy of $^{99m}$Tc-MIBI in the assessment of IVLBCL. We present one case of IVLBCL that showed $^{99m}$Tc-MIBI accumulation in the involved bone marrow as an incidental finding, which was discrepant from that of $^{18}$F-FDG PET.

• 핵의학기술
• /
• 제18권2호
• /
• pp.68-72
• /
• 2014

핵의학 검사는 반감기로 인한 동위원소의 잔류로 당일에 두 가지 검사를 시행하는데 어려움이 있다. 본 연구는 $^{18}F$-FDG와 $^{99m}TcO_4{^-}$의 상호 영향을 연구함으로써 당일 검사를 진행할 경우 고려될 사항에 대해 알아보고자 한다. NEMA-1994 Phantom을 이용하여 세 번의 실험을 진행했다. 첫 실험은 $^{99m}TcO_4{^-}$을 HOT과 BKG 비 4:1로 만들어 GE사의 INFINIA 장비로 SPECT를 시행하였고, BKG 영역에 $^{18}F$-FDG 37 MBq을 주입 후 동일 조건으로 60분에 1회씩 13회 Scan 했다. 두 번째는 $^{18}F$-FDG를 HOT과 BKG 비 4:1 로 만들어 GE사의 PET/CT Discovery 600 에서 Scan 하였고, BKG 영역에 $^{99m}TcO_4{^-}$을 148 MBq 주입 후 동일 조건으로 60분에 1회씩 6회 Scan 했다. 마지막 실험은 $^{18}F$-FDG를 HOT과 BKG 비 4 : 1로 만들고 1 Bed Scan 후 $^{99m}TcO_4{^-}$을 148 MBq 및 296 MBq씩 증가 시키며 같은 조건으로 1 Bed Scan했다. HOT과 BKG 영역의 비, CNR 혹은 SNR 그리고 총 획득 계수를 측정 후 비교 했다. $^{18}F$-FDG는 SPECT 시행 시 비율 및 CNR에 유의한 차이를 보였다(p>0.05). $^{99m}TcO_4{^-}$는 PET/CT 시행 시 비율 및 SNR이 유의한 차이를 보이지 않았다(p<0.05). $^{99m}TcO_4{^-}$이 PET/CT 검사의 Total Counts를 감소시킨다는 결과를 획득했다. PET/CT 검사를 한 경우 12시간 까지도 $^{99m}TcO_4{^-}$을 이용한 검사에 영향을 미칠 수 있으며, $^{99m}TcO_4{^-}$를 먼저 시행한 경우에는 PET/CT 검사에 SUV 및 SNR에 영향은 없지만 검출 효율을 감소시켰다. 당일 검사 시에는 $^{99m}TcO_4{^-}$을 이용한 검사를 먼저 진행하고 PET/CT의 검사 시간을 늘려 검출 효율을 보완하는 방법을 권장하고자 한다.

• Korean Journal of Radiology
• /
• 제21권7호
• /
• pp.829-837
• /
• 2020

Objective: The aim of this study was to investigate the prognostic value of the maximum standardized uptake value (SUV_max) measured while restaging with F-18 fluorodeoxyglucose (¹⁸F-FDG) positron emission tomography/computed tomography (PET/CT) to predict the 3-year post-recurrence survival (PRS) in patients with recurrent gastric cancer after curative surgical resection. Materials and Methods: In total, 47 patients with recurrent gastric cancer after curative resection who underwent restaging with ¹⁸F-FDG PET/CT were included. For the semiquantitative analysis, SUV_max was measured over the visually discernable ¹⁸F-FDG-avid recurrent lesions. Cox proportional-hazards regression models were used to predict the 3-year PRS. Differences in 3-year PRS were assessed with the Kaplan-Meier analysis. Results: Thirty-nine of the 47 patients (83%) expired within 3 years after recurrence in the median follow-up period of 30.3 months. In the multivariate analysis, SUV_max (p = 0.012), weight loss (p = 0.025), and neutrophil count (p = 0.006) were significant prognostic factors for 3-year PRS. The Kaplan-Meier curves demonstrated significantly poor 3-year PRS in patients with SUV_max > 5.1 than in those with SUV_max ≤ 5.1 (3-year PRS rate, 3.5% vs. 38.9%, p < 0.001). Conclusion: High SUV_max on restaging with ¹⁸F-FDG PET/CT is a poor prognostic factor for 3-year PRS. It may strengthen the role of ¹⁸F-FDG PET/CT in further stratifying the prognosis of recurrent gastric cancer.

• Nuclear Medicine and Molecular Imaging
• /
• 제42권4호
• /
• pp.328-332
• /
• 2008

Simple bone cyst (SBC) is very rare in adult ribs. The diagnosis basically relies on conventional radiography and occasionally on a. There has been no earlier publication on PET/CT diagnosis of SBC. We report a case of adult costal SBC diagnosed by positive $^{18}F$-fluorodeoxyglucose (FDG) uptake. Histology showed the FDG uptake to be associated with reactive woven bone formation and nonspecific chronic inflammation. Correlation of PET, CT, plain radiography and sonography are also described.

• Nuclear Medicine and Molecular Imaging
• /
• 제42권3호
• /
• pp.256-258
• /
• 2008

Osteopoikilosis is a rare, benign hereditary disease, which presents multiple osteosclerotic, and small round nodules in the bone. It is usually detected incidentally by radiological examination. A radionuclide bone scintigraphy is essential in distinguishing osteopoikilosis from osteoblastic metastases, because scintigraphic findings are usually normal in patients with osteopoikilosis. However, there have been no reports about F-18 fluorodeoxyglucose (FDG) PET findings in osteopoikilosis. Herein, we wish to report a case of osteopoikilosis with breast cancer, which could not be seen in either bone scintigraphy or F-18 FDG PET/CT.